Matzuka, B., Hazra, A., Masinde, S., Harnisch, L., Davis, J., Rodriguez-Otero, P., Mateos, M., San-Miguel, J., Boyapati, A., Jin, Y., Kroog, G. S., Sarkaria, S., Glass, J., Chittenden, J. (2026). An integrated population pharmacokinetic/pharmacodynamic (popPK/PD) model to select the linvoseltamab (LINVO) dosing regimen in patients with high-risk smoldering multiple myeloma (HR-SMM).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7525